(Q34305854)

1 August 2017

1 reference

title

The endocannabinoid nervous system: unique opportunities for therapeutic intervention (English)

1 reference

1 August 2017

endocannabinoid system

0 references

1 reference

A C Porter

1

1 reference

PubMed ID

11448725

1 August 2017

C C Felder

series ordinal

2

1 reference

1 August 2017

1 April 2001

1 reference

Pharmacology & Therapeutics

1 August 2017

1 reference

1 August 2017

90

1 reference

1 August 2017

45-60

1 reference

1 August 2017

1

1 reference

In-vitro and in-vivo action of cannabinoids.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid-receptor expression in human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Potentiation of anandamide hypotension by the transport inhibitor, AM404

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Production and physiological actions of anandamide in the vasculature of the rat kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Biochemistry of the endogenous ligands of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Prospects for pharmacological intervention in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

N-acylethanolamine accumulation in infarcted myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The endogenous cannabinoid system and brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

A single dose study of nabilone, a synthetic cannabinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Antianxiety effect of cannabidiol in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

AM630 is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Functional CB1 cannabinoid receptors in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Two distinctive antinociceptive systems in rats with pathological pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid transmission and pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Recent advantages in cannabinoid research

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

An analgesia circuit activated by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Endocannabinoids: a new class of vasoactive substances

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Role of the endogenous cannabinoid system in the regulation of motor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabis for migraine treatment: the once and future prescription? An historical and scientific review.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The N-acylation-phosphodiesterase pathway and cell signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide and other N-acylethanolamines in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

1 reference

7 January 2021

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide amidohydrolase (fatty acid amide hydrolase).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide amidohydrolase from porcine brain. Partial purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Mesenteric vasodilation mediated by endothelial anandamide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Pain modulation by release of the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Distribution and characterization of anandamide amidohydrolase in mouse brain and liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

The anandamide transport inhibitor AM404 activates vanilloid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900130-9

7 January 2021

10.1016/S0163-7258(01)00130-9

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11448725